Alexithymia Intervention for Suicide
Alexithymia Intervention for Suicide (ALEXIS)
VA Office of Research and Development
40 participants
Oct 1, 2023
INTERVENTIONAL
Conditions
Summary
Suicide rates among Veterans with Serious Mental Illness (SMI) are intractably high, representing a serious public health concern and a critical target for interventions. Yet, at present available treatments offer modest benefits. Thus, there remains an urgent need to identify novel approaches to address suicide risk in this population. Previous reports have linked suicide risk with poor social functioning. Emerging evidence from basic affective neuroscience research has indicated that effective social functioning is contingent on intact emotion awareness. Consistent with these findings, individuals with SMI at risk of suicide display social functioning difficulties along with poor emotion awareness (i.e., alexithymia). Employing a proof-of-concept design, the aim of the present study is to test the feasibility and acceptability of a novel, blended psychoeducation and digital mHealth (mobile health) intervention with smartphones designed to target alexithymia and poor social functioning to reduce suicide risk in Veterans with SMI.
Eligibility
Inclusion Criteria8
- a DSM-V diagnosis of PTSD
- bipolar disorder
- MDD
- schizophrenia
- at risk of suicide(Columbia Suicide Severity Rating Scale
- C-SSRS \>=3 or a suicide attempt in the past 5 years)
- limited emotion awareness (Toronto Alexithymia Scale; TAS-20 \>=52)
- can understand all the study's risks and benefits
Exclusion Criteria3
- have medical/neurological conditions that could interfere with study participation
- enrolled in another treatment study
- unable/unwilling to provide a verifiable contact for emergency purposes
Interventions
Intervention involving psychoeducation and daily emotion awareness practices
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05724953